MetaVia Inc. Common Stock

MTVANASDAQ • USD
1.30 USD
↘ 0.01 (0.38%)🟢PRE MARKET (AS OF 08:40 AM EST)
🟢Market: OPEN

MetaVia Inc. Common Stock (MTVA) trades at $1.30 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest MTVA is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.34
High?$1.34
Low?$1.28
Prev. Close?$1.30
Volume?1.6K
Avg. Volume?151.4K
VWAP?$1.28
Rel. Volume?0.01x
Bid / Ask
Bid?$1.10 × 100
Ask?$1.66 × 100
Spread?$0.56
Midpoint?$1.38
Valuation & Ratios
Market Cap?8.6M
Shares Out?5.2M
Float?3.4M
Float %?65.2%
P/E Ratio?N/A
P/B Ratio?1.26
EPS?-$2.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MetaVia Inc is a clinical-stage biotechnology company focused on developing treatments for liver-related cardiometabolic diseases. Its product pipeline includes DA-1726, an oxyntomodulin analogue that acts as a dual GLP-1 and glucagon receptor agonist, being developed for metabolic and alcohol-associated liver diseases. The company is also developing vanoglipel (DA-1241), a GPR119 agonist, in combination with resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Employees
8
Market Cap
8.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-08-04
Address
545 CONCORD AVENUE
CAMBRIDGE, MA 02138
Phone: (857) 702-9600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-18.97Distress
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.67%Low
Short Interest?56.1K
Days to Cover?1.0
Free Float3.4M
Avg Daily Volume70.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.06Strong
Quick Ratio?2.06Strong
Cash Ratio?1.99Strong
Debt/Equity?0.42Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
92
1.26CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-211.8%WEAK▾
ROA?
S&P
3
-108.9%WEAK▾
Cash Flow & Enterprise
FCF?$-15835000
Enterprise Value?$-1221469
Fundamentals ratios updated end of day